164 related articles for article (PubMed ID: 2468337)
1. The expression and function of CD3 and CD5 in patients with primary Sjögren's syndrome.
Dauphinée MJ; Tovar Z; Ballester A; Talal N
Arthritis Rheum; 1989 Apr; 32(4):420-9. PubMed ID: 2468337
[TBL] [Abstract][Full Text] [Related]
2. 'Fetal-type' B and T lymphocytes in rheumatoid arthritis and primary Sjögren's syndrome.
Plater-Zyberk C; Brennan FM; Feldmann M; Maini RN
J Autoimmun; 1989 Jun; 2 Suppl():233-41. PubMed ID: 2476142
[TBL] [Abstract][Full Text] [Related]
3. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
Vandenberghe P; Ceuppens JL
Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD3 and anti-CD2-induced T-cell activation in primary Sjögren's syndrome.
Gerli R; Bertotto A; Cernetti C; Agea E; Crupi S; Arcangeli C; Spinozzi F; Galandrini R; Rambotti P
Clin Exp Rheumatol; 1989; 7 Suppl 3():S129-34. PubMed ID: 2575023
[TBL] [Abstract][Full Text] [Related]
5. Characterization of normal human CD3+ CD5- and gamma delta T cell receptor positive T lymphocytes.
Spour EF; Leemhuis T; Jenski L; Redmond R; Fillak D; Jansen J
Clin Exp Immunol; 1990 Apr; 80(1):114-21. PubMed ID: 1691061
[TBL] [Abstract][Full Text] [Related]
6. Coordinate expansion of 'fetal type' lymphocytes (TCR gamma delta+T and CD5+B) in rheumatoid arthritis and primary Sjögren's syndrome.
Brennan F; Plater-Zyberk C; Maini RN; Feldmann M
Clin Exp Immunol; 1989 Aug; 77(2):175-8. PubMed ID: 2476268
[TBL] [Abstract][Full Text] [Related]
7. The role of protein kinase C in transmembrane signaling by the T cell antigen receptor complex. Effects of stimulation with soluble or immobilized CD3 antibodies.
Manger B; Weiss A; Imboden J; Laing T; Stobo JD
J Immunol; 1987 Oct; 139(8):2755-60. PubMed ID: 3116093
[TBL] [Abstract][Full Text] [Related]
8. Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.
Gerli R; Bertotto A; Agea E; Lanfrancone L; Cernetti C; Spinozzi F; Rambotti P
J Clin Invest; 1990 Dec; 86(6):1870-7. PubMed ID: 1979333
[TBL] [Abstract][Full Text] [Related]
9. Recovery of CD3+ and CD5- lymphocyte subpopulation after autologous bone marrow transplantation and chemotherapy.
McKay PJ; McLaren A; Andrews LM; Lucie NP
J Clin Pathol; 1991 Mar; 44(3):259-61. PubMed ID: 1707418
[TBL] [Abstract][Full Text] [Related]
10. T cells bearing gamma/delta T cell receptor and their expression of activation antigen in peripheral blood from patients with Sjögren's syndrome.
Ichikawa Y; Shimizu H; Yoshida M; Takaya M; Arimori S
Clin Exp Rheumatol; 1991; 9(6):603-9. PubMed ID: 1722441
[TBL] [Abstract][Full Text] [Related]
11. Characterization of peripheral blood and salivary gland lymphocytes in Sjögren's syndrome.
Celenligil H; Kansu E; Ruacan S; Eratalay K; Irkeç M
Oral Surg Oral Med Oral Pathol; 1990 May; 69(5):572-7. PubMed ID: 2139722
[TBL] [Abstract][Full Text] [Related]
12. T cell receptor expression in Sjögren's syndrome.
Zumla A; Mathur M; Stewart J; Wilkinson L; Isenberg D
Ann Rheum Dis; 1991 Oct; 50(10):691-3. PubMed ID: 1720300
[TBL] [Abstract][Full Text] [Related]
13. B cells expressing CD5 are increased in Sjögren's syndrome.
Dauphinée M; Tovar Z; Talal N
Arthritis Rheum; 1988 May; 31(5):642-7. PubMed ID: 3259883
[TBL] [Abstract][Full Text] [Related]
14. CD5 positivity on peripheral blood B lymphocytes in patients with primary Sjögren's syndrome.
Zeher M; Surányi P; Szegedi G
Allergol Immunopathol (Madr); 1990; 18(2):75-8. PubMed ID: 1695475
[TBL] [Abstract][Full Text] [Related]
15. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
16. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
[TBL] [Abstract][Full Text] [Related]
17. Induction of human T cell proliferation by a monoclonal antibody to CD5.
Spertini F; Stohl W; Ramesh N; Moody C; Geha RS
J Immunol; 1991 Jan; 146(1):47-52. PubMed ID: 1701800
[TBL] [Abstract][Full Text] [Related]
18. Immunodeficiency with low expression of the T cell receptor/CD3 complex. Effect on T lymphocyte activation.
Le Deist F; Thoenes G; Corado J; Lisowska-Grospierre B; Fischer A
Eur J Immunol; 1991 Jul; 21(7):1641-7. PubMed ID: 1676369
[TBL] [Abstract][Full Text] [Related]
19. Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression.
Miescher S; Stoeck M; Qiao L; Barras C; Barrelet L; von Fliedner V
Int J Cancer; 1988 Nov; 42(5):659-66. PubMed ID: 2972629
[TBL] [Abstract][Full Text] [Related]
20. A large proportion of T lymphocytes lack CD5 expression after bone marrow transplantation.
Bierer BE; Burakoff SJ; Smith BR
Blood; 1989 Apr; 73(5):1359-66. PubMed ID: 2467708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
